Founded in 1998, Genopole is the oldest and largest biocluster in France. It was launched thanks to the impetus of local public authorities such as France’s muscular dystrophy association (i.e., AFM-Téléthon) and France’s Ministry of Higher Education and Research. The sponsors of Genopole are currently the governments of the Region Île-de-France and the Department of Essonne, the City of Évry, as well as France’s Ministry of Higher Education, Research & Innovation.
Genopole’s focus is genomics-driven R&D and innovation. Genopole aims to enable the emergence of innovations that will improve growth, health economy, citizens’ health and environment.
The biocluster was a pioneer in France’s government-led biotechnology thrust of the late 90’s and has since grown to become one of the leading European world-class biotech hotspots that attracts and networks from new raising biotech stars (start-ups) to dynamic established SMEs/companies, as well as a number of public research laboratories and higher education stakeholders from the local Université d’Évry Paris-Saclay and the Hospital Center of South Grand Paris (Centre Hospitalier Sud-Francilien). Today, by offering the environnement and insfrastructures for bioentrepreneurs, Genopole is a leading-edge cluster in human, animal and microbial genetics, as well as has outstanding expertise in the field of innovative biotherapies, personalized medicine and industrial biotechnologies.
Genopole’s biotechcampus has excellent location factors: it is located in the neighboring cities of Évry and Corbeil-Essonnes in the Department of Essonne. Genopole is 20km from Orly Airport and 70km from Charles-de-Gaulle Airport, easily reachable by highway. Genopole is also easily accessible from Paris by public transport from main Paris railtrain stations.
Genopole is also strategically located on the south side of “Grand Paris” allowing to strenghen local and regional, sectorial and cross-sectorial collaborations/opportunities with a very dynamic scientific and technological ecosystem, as the Department of Essonne hosts a number of reputed academic institutions (École Polytechnique, Supelec, Télécom SudParis, Institut Mines-Télécom Business School, Centre des matériaux de l’École des mines), well-renowned public research institutes and organizations (CEA, CNRS, Curie, Institut Gustave Roussy, Inra, Inserm, Inria, Onera), as well as state-of-the-art scientific infrastructures (Synchrotron Soleil, NeuroSpin, Teratec). Moreover, the Department of Essonne is one of the few French departments to develop on its territory a technology ranging from the incubation of a project to its industrial application. Two sectors of excellence stand out: biotechnologies and optics / ICT (so called Optics Valley)
Today, thanks to a committed cluster management over 20 years, Genopole at a glance represents a mature and fertile cluster organisation with more than 2,300 staff members which are employed on-site by the 83 companies, 17 public research labs, and 25 cutting -edge shared-access technology platforms and facilities for R&D located on site. This unique Life Science ecosystem, including an hospital, a centre for clinical and transnational research and an University has provided nourishing environnement particularly for over 200 start-ups which have been accredited by Genopole over the last two decades, and have been assisted though customised specialised R&D and business support services. During that period, over €926 million have been raised by Genopole’s portfolio companies, and seven companies have been already listed on public markets.
Genopole’s overall mission is to support R&D in genomics and genetics and the grow of biotechnology SMEs that pursue health, environmental and agri-food applications.
Genopole is a not-for-profit organisation (with a permanent staff of 48 pers.) which is acting as general manager, advocate, promoter, catalyst, facilitator, coordinator, and sometimes financial sponsor of the biocluster member’s developments.
Genopole’s principal objectives are to:
- Support and coordinate R&D efforts and innovation initiatives in genomics and post-genomics sciences and technology;
- Promote the growth of French biotechnology markets through direct incubation and business support services to start-ups and early-stage companies;
- Provide cutting-edge shared-access technological platforms to the laboratories and companies that request them to conduct their researches;
- Provide entrepreneurship training programmes, as well as reinforce targeted teaching programmes in close collaboration with the Université d’Evry Paris-Saclay and the Université Paris-Saclay;
- Facilitate communications between the biocluster’s stakeholders by organizing scientific and networking events on site as well as by reaching out to the media and the general public at large to generate a better understanding of the positive impact of genomics;
- Participate in the societal debate on ethical issues related to the development of biotechnology and human genomic research.
Established - 23 October 1998
Staff in the management team - over 30
Support services for upskilling and reskilling of companies workforce
20Number of start-ups among SME's
17Research Organisations, Universities, Technology Centers
0Number of civil society members
18Other Ecosystem Actors